Peter Kertes's guest appearances

Peter Kertes

The Retina Channel Podcast

David Brown

Jason Hsu

Pravin Dugel

David Almeida

Mark Gillies

Richard Rosen

Mark Humayun

Rajeev Muni

Jennifer Sun

Cecilia Lee

Matthew Schrag

Camiel Boon

Usha Chakravarthy

Sean Adrean

Charles Wykoff

OwlTail

Extend

Dr. Peter Kertes discusses the publication of the first year results of the CANTREAT study that investigates monthly vs treat-and-extend dosing of ranibizumab for wet AMD.    Full reference: Kertes, P. J., Galic, I. J., Greve, M., Williams, R. G., Rampakakis, E., Scarino, A., &amp; Sheidow, T. (2019). Canadian Treat and Extend Analysis Trial with Ranibizumab in Patients with Neovascular Age-related Macular Disease: 1-Year Results of the Randomized CANTREAT Study. Ophthalmology. doi:10.1016/j.ophtha.2019.01.013

Dr. Peter Kertes discusses the publication of the first year results of the CANTREAT study that investigates monthly vs treat-and-extend dosing of ranibizumab for wet AMD.  Full reference: Kertes, P. J., Galic, I. J., Greve, M., Williams, R. G., Rampakakis, E., Scarino, A., &amp; Sheidow, T. (2019). Canadian Treat and Extend Analysis Trial with Ranibizumab in Patients with Neovascular Age-related Macular Disease: 1-Year Results of the Randomized CANTREAT Study. Ophthalmology. doi:10.1016/j.ophtha.2019.01.013

E23- CANTREAT Study. Ranibizumab Monthly vs Treat-and-Extend for wAMD - Dr. Peter Kertes